logo
Login
Open Account
Open Demat

Sector: Pharmaceuticals & Biotechnology

|

Mid Cap

Procter & Gamble Health Share Price

Procter & Gamble Health Ltd.

₹4,812.80

14.00(0.29%)

Invest in PGHL with up to 3.33x margin.

Trade with MTF
1st Apr 2026 | 3:11 PM
NSE : PGHL
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Procter & Gamble Health Performance

Price Movement

₹4812.80

₹4799.90

₹4872.80

↘ Today's Low↗ Today's High

1 Year Performance

₹4812.80

₹4780.00

₹6739.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹4,872.80
Low₹4,799.90
Open at₹4,829.00
Prev Close₹4,798.80
Volumes10.11 K
Avg Price₹4,828.24
Lower Circuit₹3,839.10
Upper Circuit₹5,758.50

Historical Performance

3M High₹5,912.00
3M Low₹4,725.00
1 Yr High₹6,739.00
1 Yr Low₹4,725.00
3 Yr High₹6,739.00
3 Yr Low₹4,575.00
5 Yr High₹6,739.00
5 Yr Low₹3,870.10

Procter & Gamble Health Fundamentals

Market Cap
Above industry Median
7,965.70 Cr.
PE Ratio (TTM)
Above industry Median
27.10
Dividend Yield
Market Runner Up
4.30
Net Profit TTM
24.1% incr over last year
293.49
Net Profit Growth
24.1% incr over last year
293.49
PEG Ratio
Above industry Median
1.10
ROE
16.9% incr over last year
43.65
Operating Revenue TTM
1,348.51
Operating Revenue Growth
16.3% incr over last year
Book Value
High in industry
11.40
MFI
MFI oversold
29.48
RSI
RSI is mid-range
39.41
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
11.40

Procter & Gamble Health Financials

*All values are in Rs. Cr
Loading chart...
Indicator
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Total Revenue373.86324.92338.74310.99309.77
Operating Expense263.40204.65248.40230.07186.34
Operating Profit110.46120.2790.3480.92123.43
Depreciation5.906.085.445.375.55
Interest0.100.120.120.130.15
Tax31.2330.4822.6317.3530.79
Net Profit77.5988.5466.1861.1890.90

Procter & Gamble Health Technicals

Procter & Gamble Health Ltd. EMA & SMA

₹4812.80

-44.60 (-0.92%)

↗ Bullish Moving Average

0

↘ Bearish Moving Average

16

Day EMA5 ₹4848.1
Day EMA10 ₹4864.9
Day EMA12 ₹4872.4
Day EMA20 ₹4911.7
Day EMA26 ₹4947.5
Day EMA50 ₹5100
Day EMA100 ₹5340.4
Day EMA200 ₹5509

Procter & Gamble Health Support and Resistance

Resistance

First Resistance₹4827.70
Second Resistance₹4856.60
Third Resistance₹4880.40

Support

First Support₹4775.00
Second Support₹4751.20
Third Support₹4722.30

Technical Indicators

Day RSI39.41
Day MFI29.48
Day ADX27.37
Day Commodity Channel Index-143.40
William-73.16
Day MACD-75.15
Day MACD Signal Line-86.60
Day ATR125.07
Day ROC125-24.64
Day ROC21-6.57

Procter & Gamble Health Shareholding Pattern

Held BySep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoter51.851.851.851.851.851.8
FII6.676.977.27
DII14.814.714.214.113.913.8
Public26.726.527.1272727.4

Procter & Gamble Health Delivery And Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume AvgDaily Avg Delivery Volume %
Day7 K11.07 K63.23%
Week7.21 K12.76 K56.49%
1 Month7.55 K12.99 K58.15%
6 Month7.23 K11.63 K62.12%

Procter & Gamble Health SWOT Analysis

Strengths12
Weakness11
Opportunity2
Threats1

Companies with no Debt

Benjamin Graham Value Screen

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Mid-range Performer (DVM)

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Dividend yield greater than sector dividend yield

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Zero Promoter Pledge

Procter & Gamble Health Corporate Action

Ex-Date
Dividend Amount
Dividend Type
Record Date
Instrument Type
12 Feb, 202650SPECIAL12 Feb, 2026Equity Share
12 Feb, 2026110INTERIM12 Feb, 2026Equity Share
22 Aug, 202545FINAL22 Aug, 2025Equity Share
21 Feb, 202580INTERIM21 Feb, 2025Equity Share
28 Nov, 202460FINALEquity Share
14 Feb, 2024150SPECIAL14 Feb, 2024Equity Share
14 Feb, 202450INTERIM14 Feb, 2024Equity Share
23 Nov, 202350FINALEquity Share
13 Feb, 202345INTERIM13 Feb, 2023Equity Share
15 Nov, 202211.5FINALEquity Share

Procter & Gamble Health Stock Comparison

Financials
Corona Remedies Ltd.
Sudeep Pharma Ltd.
Rubicon Research Ltd.
OneSource Specialty Pharma Ltd.
Sanofi Consumer Healthcare India Ltd.
Akums Drugs & Pharmaceuticals Ltd.
Price (₹)₹1,550₹612.35₹780.95₹1,444.80₹4,532.50₹495.55
% Change-0.39%3.34%1.05%-1.93%5.45%6.32%
Revenue TTM (₹ Cr)--₹1,598.19₹1,419.33₹878.40₹4,256.70
Net Profit TTM (₹ Cr)--₹206.20₹20.10₹240.10₹318.19
PE TTM--61.70840.1041.2023.10
1 Year Return46.52-0.0859.34-15.92-10.95-1.5
ROCE30.2434.7834.763.26-11.27

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 350.95

+7.24%

CONCORDBIO

Concord Biotech Ltd.

₹ 1020.00

+0.16%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 632.60

+6.87%

PPLPHARMA

Piramal Pharma Ltd.

₹ 142.65

+4.47%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2346.10

-8.31%

ALIVUS

Alivus Life Sciences Ltd.

₹ 982.15

+0.97%

COHANCE

Cohance Lifesciences Ltd.

₹ 312.15

+3.55%

ERIS

Eris Lifesciences Ltd.

₹ 1307.70

+0.81%

SYNGENE

Syngene International Ltd.

₹ 395.80

+1.51%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 674.10

+1.64%

STAR

Strides Pharma Science Ltd.

₹ 964.95

+2.90%

GRANULES

Granules India Ltd.

₹ 628.90

+1.37%

WOCKPHARMA

Wockhardt Ltd.

₹ 1269.10

+7.94%

FDC

FDC Ltd.

₹ 328.35

+2.26%

SHILPAMED

Shilpa Medicare Ltd.

₹ 374.55

+7.35%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 816.65

+0.02%

NATCOPHARM

Natco Pharma Ltd.

₹ 1002.55

+2.91%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1576.10

+4.74%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 12596.00

+4.73%

MARKSANS

Marksans Pharma Ltd.

₹ 168.31

+7.28%

SANOFI

Sanofi India Ltd.

₹ 3268.50

+1.83%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 589.70

+9.26%

FAQ's on PGHL

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy